(P080) Immune Parameters as Predictors of Pneumonitis and Survival in Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.02.176
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Timing of Surgery After Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Genotypes and Haplotypes of the VEGF Gene and Survival in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Predictors of Long-Term Survival Among Locally Advanced Non–small Cell Lung Cancer Patients Undergoing Definitive Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Functional Dose-Volume Histograms for Predicting Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated With Late-Course Accelerated Hyperfractionated Radiotherapy

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2011English

Modeling Tumor Dynamics and Overall Survival in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently With Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

MA10.06 Impact of Immune-Related Adverse Events on Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Fever and Survival With Drug-Treated Non-Small Cell Lung Cancer.

Kurume Medical Journal
Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy